Depression is more common in patients with diabetes than in the general population so nurses should be aware of this and screen for it routinely
In this article…
- The impact of depression on a person with diabetes
- Course of depression
- Screening and management
Kirsty Winkley is a diabetes specialist nurse, National Institute for Health Research post-doctoral fellow and lecturer in diabetes at the Institute of Psychiatry, King’s College London.
Winkley K (2013) Depression and diabetes: what should nurses do? Nursing Times; 109: 45, 20-22.
Depression is recognised as a major health problem for people with diabetes and is associated with morbidity, mortality and a poor quality of life. This article outlines how depression is diagnosed, its consequences and how to screen for and treat it. It also gives some practical tips that nurses can use to support patients with diabetes who have depression.
- This article has been double-blind peer reviewed
- Figures and tables can be seen in the attached print-friendly PDF file of the complete article in the ‘Files’ section of this page
5 key points
- It is thought that 5-30% of people with diabetes also have depression
- Nurses are well placed to screen for depression and coordinate subsequent management
- Low mood, loss of interest in everyday activities and fatigue are the three main symptoms of depression
- People with depression may drastically increase or decrease their contact with health services
- Patients with depression and diabetes need increased input into their diabetes treatment
Depression is common in people with diabetes. It is thought that 5-30% of people with diabetes are affected - in general, double the number of people usually affected by depression who have no long-term illness (Anderson et al, 2001). These higher rates of depression have been found in studies using self-reporting measures, rather than the psychiatric interview techniques often used by mental health professionals.
Diagnosis of depression
According to criteria from the 10th edition of the International Classification of Diseases depression has three main symptoms:
- Low mood;
- Loss of interest in everyday activities;
- Fatigue or low energy.
If one or more of these symptoms are present, it is important to find out if there are any additional symptoms to determine the severity of depression. These include:
- Disturbed sleep;
- Poor concentration;
- Low self-confidence;
- Poor or increased appetite;
- Ideas or acts of self-harm or suicide;
- Slowing of movements;
- Guilt or self-blame (National Institute for Health and Clinical Excellence, 2009).
Severity of depression is assessed by determining the number and severity of the depressive symptoms outlined above, usually over a minimum of two weeks:
- <4 - no depression;
- ≥4 - mild depression;
- 6-7 - moderate depression;
- ≥8 - severe depression.
Categorising in this way may direct the type of treatment that is provided. As a rule of thumb, a depressive episode can be distinguished from a period of sadness by symptoms lasting longer than two weeks, occurring on most days of the week and there being a distinct loss of functioning.
Risk factors for depression
Risk factors for depression in people with diabetes are often similar to those for the general population. For example, depression is more common in women, younger people, those who have had stressful life events, people who live alone or have low levels of social support, those with lower socioeconomic status and those with additional health problems (usually affecting older people) (Winkley, 2008).
In addition to these common risk factors, particular factors are associated with depression in people with diabetes:
- Diabetes complications;
- Longer duration of diabetes;
- Severe diabetes;
- Little physical activity;
- Dependency on others;
- Persistent poor glycaemic control;
- Problems with hypoglycaemia;
- Patients with type 2 diabetes who are treated with insulin (Winkley, 2008).
Depression is a risk factor for type 2 diabetes but diabetes is also a risk factor for subsequent depression (Nouwen et al, 2010). This suggests the two conditions share common pathways as both are associated with physical inactivity, obesity and cardiovascular disease.
Course of depression
Few studies have examined depression in people with diabetes but the available evidence suggests depression is more chronic in people with diabetes than in general population samples (Winkley, 2008). For example, 64% of people with both depression and diabetes have depression with a relapse-remitting course (relapse is defined as a worsening of mood within a nine-month period), 15% never recover from their depression, and only around 20% recover fully (Lustman et al, 1997).
Adverse effects of depression
The effects of depression can be detrimental to health, quality of life and personal relationships. However, when people also have diabetes, it is common for them to increase their use of health service resources and reduce their adherence to their diabetes self-management programme, such as eating less healthily, reducing physical activity and not adhering to oral medications. Cognitive dysfunction can also be problematic and is common with diabetes and depression.
It is not fully understood why risk of mortality is higher for people with diabetes and depression, but there is consistent, international evidence suggesting a link. In both the UK and US, studies confirm that affected patients are two to five times more likely to die earlier when they have both comorbid conditions (Ismail et al, 2007; Black et al, 2003).
In the UK, a cohort of patients with their first diabetic foot ulcer and with minor and major depression were three times more likely to die at 18-month follow-up and these effects persisted at five years (Winkley et al, 2012; Ismail et al, 2007). In the US Pathways study, a cohort of 4,385 people with type 2 diabetes followed up for three years found a 1.67-fold increase in mortality in those with minor depression and a 2.3-fold increase in those with major depression (Katon et al, 2005) compared with those with no depression.
The US National Health and Nutrition Examination Survey found that diabetes patients with depression were 2.5 times more likely to die from all-cause mortality and 2.43 times more likely to die from coronary heart disease than the general population (Egede et al, 2005). Finally, a longitudinal study of Mexican Americans with type 2 diabetes aged 65 years and over were found to be almost five times more likely to die if depressed at a seven-year follow-up and were significantly more likely to develop an earlier onset of diabetes complications than those without depression (Black et al, 2003).
Having depression and diabetes has significant costs to individuals and society but the mechanisms that start to explain why this is the case are complex and thought to involve interactions between biological, psychological and social processes.
Simple psychological explanations suggest people with depression and diabetes are less likely to look after themselves and perform adequate self-management, evidence of which is seen in the literature.
Social explanations might also add to this, for example if people are depressed they may be more likely to be socially isolated, without social support and perhaps at a disadvantage in maintaining good personal relationships. This can have far-reaching consequences, limiting their capacity for work and study, and increasing their chances of experiencing poverty.
Biological explanations suggest depression influences cardiovascular health and macrovascular complications through activation of the hypothalamic pituitary adrenal axis or through immune system dysfunction (McCaffery et al, 2006). In depression, the hypothalamic pituitary axis is overstimulated and the associated sympathetic response may increase cardiovascular risk in several ways. For example, more counter-regulatory stress hormones that raise blood-glucose levels are released leading to insulin resistance (Brotman et al, 2007); there is also increased platelet activity and atherosclerosis (Musselman et al, 1996), and altered autonomic tone leading to decreased heart rate variability (Carney et al, 1995).
Genetic and environmental interactions may also play a role - obesity, insulin resistance and hypertension tend to be grouped together (Stunkard et al, 2003). Common effects of depression are listed in Box 1.
Depression screening, management and support
Depression in people with diabetes was recognised by the NHS as a priority; depression screening was included in the UK diabetes review but has recently been removed from the Quality and Outcomes Framework assessment. NICE (2009) guidelines suggest GPs and practice nurses play an active role in assessment. Recommendations for treating mild depression include:
- Watchful waiting by the primary care health team;
- Guided self-help;
- Computerised cognitive behavioural therapy;
- Brief psychological interventions and exercise.
For moderate to severe depression, more complex psychological interventions and pharmacotherapy are recommended.
Many nurses will be familiar with the two-item screen for depression, which asks patients if they have low mood or have lost interest in everyday activities. If the patient answers “yes” to either question, the degree of depressive symptoms is then assessed with a validated questionnaire such as the Patient Health Questionnaire (Kroenke et al, 2001) or the Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983). A positive score on either does not mean the patient has depression but does indicate they should be assessed by an experienced clinician.
Some patients with diabetes may not realise they have depression; instead they may report having difficulty managing their diabetes, perhaps linked to increased symptoms, and are at the point of giving up on their self-management. Others may report anxiety or eating problems, which may be related to depression, such as emotional eating, binging or purging.
Now routine screening in primary care settings is no longer part of the QOF assessment, some patients with diabetes and depression will remain unidentified. Others with depression may not be detected because of stigma, language barriers, cognitive problems and disengagement with health services. Some patients deny having depressive symptoms as it is not thought culturally acceptable; these may report increased somatisation (physical symptoms) instead. Screening may be difficult due to language barriers and cognitive problems; many patients simply stop attending their regular appointments.
Management and support
Depression treatment for people with diabetes is largely successful, be it through psychological therapy, drugs or both.
In Lambeth and Southwark, in London, a new initiative in service delivery has targeted people with psychological problems who have persistent, poorly controlled diabetes, as well as social problems, that prevent them from managing their diabetes effectively. The 3 Dimensions of Care For Diabetes, led by Professor Khalida Ismail, fully integrates medical, psychological and social care, and works with the Intermediate Diabetes Team in the community. The aim is to improve diabetes control and quality of life. This service is new and it is not yet clear whether it will be cost effective in the long term but, if so, it may provide another referral route for patients.
Once detected or suspected, depression should be treated quickly. For many people with a mild depressive episode, guided self-help is recommended. Several websites and self-help guides are routinely recommended to patients; examples are Beating the Blues (www.beatingtheblues.co.uk), an online CBT course, and Mood Gym (www.moodgym.anu.edu.au), which is free. Exercise is also excellent for treating mild depression as it helps people regain a sense of control over their lives and has additional health benefits for those with diabetes. “Watchful waiting” can also be helpful; this means keeping in touch with the patient, offering regular phone calls and follow-up.
Patients who prefer one-to-one or brief psychological therapy may be able to access direct help via the Improving Access to Psychological Therapy service. Patients may be able to self-refer or access treatment through their GP. Now rolled out across England; the IAPT service offers an online training course to health professionals via the Royal College of General Practitioners website (www.tinyurl.com/RCGP-IAPT).
Moderate to severe depression
With moderate to severe depressive episodes, patients may need specialist psychological intervention or medication, the availability of which may depend on where they live. Patients may benefit most when services are provided by specialist diabetes mental health professionals. However, specialist psychological services are not widely available; a report commissioned by Diabetes UK (2008) found only 15% of diabetes services had access to these.
Antidepressants are readily available and successful but patients may not notice any improvement in their symptoms for at least two weeks; it may take longer than this for patients to receive a therapeutic dose.
Practical aspects of management
When patients are depressed it may seem the best and only thing to do is find treatment for their depression. However, good overall care is still necessary and nurses may be best placed to coordinate this. Practical tips are outlined in Box 2.
Depression is common for people with diabetes. However, screening for depression can detect most of these who are affected and treatment is usually successful. Nurses involved in the care of people with diabetes are well placed to screen for depression and coordinate subsequent treatment. Good overall care for both conditions will provide patients with the most benefit.
Anderson RJ et al (2001) The prevalence of co-morbid depression in adults with diabetes. Diabetes Care; 6, 1069-1078.
Black SA et al (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care; 26, 2822-2828.
Brotman DJ et al (2007) The cardiovascular toll of stress. Lancet; 22: 1089-1100.
Carney RM et al (1995) Association of depression with reduced heart rate variability in coronary artery disease. American Journal of Cardiology; 76: 562-564.
Diabetes UK (2008) Minding the Gap: The Provision of Psychological Support and Care for People with Diabetes in the UK. London: Diabetes UK.
Egede LE et al (2005) Depression and all-cause and coronary mortality among adults with and without diabetes. Diabetes Care; 28: 1339-1345.
Ismail K et al (2007) A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care; 30: 1473-1479.
Katon WJ et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care; 28: 2668-2672.
Kroenke K et al (2001) The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine; 16: 606-613.
Lustman PJ et al (1997) The course of major depression in diabetes. General Hospital Psychiatry; 19: 138-143.
McCaffery JM et al (2006) Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosomatic Medicine; 68: 187-200.
Musselman DL et al (1996) Exaggerated platelet reactivity in major depression. American Journal of Psychiatry; 153: 1313-1317.
National Institute for Health and Clinical Excellence (2009) Depression: Management of Depression in Primary and Secondary Care. London: NICE.
Nouwen A et al (2010) Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia; 53, 2480-2486.
Stunkard AJ et al (2003) Depression and obesity. Biological Psychiatry; 54, 330-337.
Winkley K et al (2012) Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality. Diabetologia; 55, 303-310
Winkley K (2008) The epidemiology of depression in diabetes. European Diabetes Nursing; 5: 91-96.
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica; 67: 6, 361-370.